New eye drops aim to soothe dry eye sufferers

NCT ID NCT06780306

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a new eye treatment called TTAX03 in 74 people with mild to moderate dry eye disease. The goal was to see if it is safe and if it can reduce eye dryness and damage. Participants received either a single dose of TTAX03 or a saline (salt water) control and were checked over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advanced Research, LLC.

    Deerfield Beach, Florida, 33064, United States

  • CORE, Inc. / Vita Eye Clinic

    Shelby, North Carolina, 28150, United States

  • Eye Associates of North Jersey

    Dover, New Jersey, 07801, United States

  • Northern New Jersey Eye Institute

    South Orange, New Jersey, 07079, United States

  • Southwest Eye Care

    Chaska, Minnesota, 55318, United States

  • University California Berkeley

    Berkeley, California, 94720, United States

  • University of Mississippi Medical Center

    Jackson, Mississippi, 39216, United States

  • Westlake Eye Specialists

    Austin, Texas, 78749, United States

  • Wilmington Eye at Brunswick Forest

    Leland, North Carolina, 28451, United States